Sheng Morgan 4
4 · Prevail Therapeutics Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Sheng Morgan
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-17+17,000→ 17,000 totalExercise: $16.98Exp: 2030-06-17→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 17, 2021 and (ii) the date immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.